Clinical trials sponsored by Kafrelsheikh University

Phase breakdown

Conditions studied

Recruiting trials led by Kafrelsheikh University

• Effect of Sodium Glucose Co-tansporter 2 Inhibitors (SGLT2I) on Inflammatory and Oxidative Stress Markers Level in Heart Failure Patients
  NCT06585761 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Impact of Combined Oral Contraceptive Pills on Migraine
  NCT06509503 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: Female · 1 location
• Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction
  NCT07192341 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Kafrelsheikh University recruiting for?

Kafrelsheikh University is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.